Indicated for: iron overload
Route of administration: oral
Substance: deferiprone (chelating agent)
ATC: V03AC02 (Various | All other therapeutic products | Iron chelating agents)
Deferiprone is an iron chelator used for the treatment of chronic iron overload in patients with major thalassemia, particularly when other treatments are not suitable. It works by binding excess iron, facilitating its elimination through urine.
The medication is taken orally, usually three times daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, vomiting, joint pain, and neutropenia.
Deferiprone is contraindicated in patients with severe neutropenia, active infections, or hypersensitivity to the active substance. Its use also requires regular monitoring of blood counts to prevent hematological complications.
This medication is an important option for patients with iron overload, helping to reduce the risk of complications associated with this condition.